China Diagnostic Reagent Industry, 2015 - Current Market Trends, Shares, Size and Forecast

ResearchMoz added Latest Research Report titled " China Diagnostic Reagent Industry, 2015: Worldwide Market Size, Shares, Trends, Growth, Survey and Forecast report " to it's Large Report database.

Logo

Albany, NY -- (SBWire) -- 03/15/2016 --After 30 years of development, the China's diagnostic reagent industry achieved a market size of nearly RMB 20 billion in 2014, a YoY growth of 15.7%. Currently nearly 90% downstream users of China's diagnostic reagent market comes from hospitals.

There's still a huge growth potential in China's diagnostic reagent industry. China accounts for 20% of total population worldwide, but only take up 7% of global diagnostic reagent market in 2014. The average diagnostic reagent expense in China is only around $3, far below the average of $28 in the developed countries.

Browse Market info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=285875

Currently there are about 300 diagnostic reagent enterprises in China and the industry concentration is still low. Large companies in China include: KHB, Da An Gene, Maker, HTA etc. Foreign brands accounts for over 50% of China's diagnostic reagent market in 2014, especially in high-end fields. The market share of domestic enterprises mainly comes from biochemical reagents.

China has fulfilled the import substitution of biochemical reagents, intensified competition has largely squeezed the profits in this subfield. Chemiluminescence Immunoassay (CLIA) and molecular diagnosis will be the most promising subfields in China's diagnostic reagent industry.

New Industries Biomedical Engineering Co., Ltd is the leading CLIA enterprise in China. Currently the company owns 102 chemiluminescent reagents and 8 models of CLIA analyzer. The company achieved reagents sales of RMB 331 million and reagents products has exported to Swiss, France, and Italy etc.

Enquiry at: http://www.researchmoz.us/enquiry.php?type=E&repid=285875

Zeesan Biotech is the leading molecular diagnosis enterprise in China. The company achieved molecular diagnosis reagents sales of RMB 11.85 million in 2014. Zeesan's products covers infectious disease (mainly phthisis), tumor (mainly leukemia) and genetic disease.

About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Latest Press-Releases: http://www.researchmoz.us/pressrelease

Media Relations Contact

Mr. Nachiket
Manager
Researchmoz Global Pvt. Ltd.
518-621-2074
http://www.researchmoz.us/

View this press release online at: http://rwire.com/672878